VP Regulatory Affairs Rizwana F Sproule sold $385K of Kite Pharma, Inc.

Sold$384,791

$45.27Price

8,500Shares

−45%Stake

What KITE did after the filing

Prices for KITE after this filing aren't in yet.

Traded Tue, Mar 15. Filed Thu, Mar 17, 5:15 PM ET, after the close. Not investment advice.